Skip to content
Head to head

Bristol-Myers Squibb vs Eli Lilly and Co

Side-by-side on the measures that matter, with a plain-English read. Full detail: BMY · LLY

Updated 4 minutes ago

1-year performance, rebased to 100

BMY +29.9%LLY +32.5%
Eli Lilly and Co edges it on the scoreable measures. Eli Lilly and Co earns the most per share.
BMYLLY
Snapshot
Sector----
Last price58.801,347.11
Change today+0.79%-0.30%
1-year return+32.3%+29.7%
Market cap$120.19B$1.27T
52-week range45.55 – 67.94846.81 – 1,475.25
Valuation
P/E (TTM)13.0443.72
P/E percentile, own 5-yr range38th29th
P/B5.1431.47
Dividend yield4.29%0.50%
Profitability & growth
EPS (TTM)3.4622.95
Net profit (TTM)$7.07B$21.59B
Revenue (TTM)$50.03B$86.46B
Provider revenue period date2026-09-292026-09-29
Revenue growth (YoY)+6.9%+38.6%
Gross margin69.2%83.6%
Operating margin29.2%51.3%
Net margin18.5%31.9%
Free cash flow (TTM)$9.29B$11.69B
Provider cash-flow period date2026-09-292026-09-29
Ownership & sentiment
Institutional ownership83.6%79.0%
Insider activity (12mo)33 buy / 17 sell33 buy / 17 sell
Short interest (% of float)2.3%0.8%
Analyst consensus47% buy / 47% hold / 6% sell (17)92% buy / 4% hold / 4% sell (24)
Analyst price target$67 (+14%)$1,524 (+13%)
StockVane view
StockVane Quant RatingD (78)C (74)
Company
Employees32,50050,000
Founded19331901

▲ marks the more favourable stock(s) on measures with a clear direction (lower P/E, higher yield, higher Quant Rating, better 1-year return). Analyst consensus counts each covering institution once, at its most recent rating. Not a recommendation. Quant Rating method: Data & Methodology.